Phase II study of carboplatin and pemetrexed in patients with recurrent platinum sensitive ovarian, fallopian tube or primary peritoneal cancer.

Trial Profile

Phase II study of carboplatin and pemetrexed in patients with recurrent platinum sensitive ovarian, fallopian tube or primary peritoneal cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Carboplatin; Pemetrexed
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Actual patient number (44) added as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top